Modificare „GUARDANT HEALTH INC”

Pagina dedicata companiei GUARDANT HEALTH INC listata cu simbolul US.GH

==Descriere companie==
Guardant Health, Inc.(www.guardanthealth.com) is a precision oncology company. The Company is focused on helping conquer cancer through use of its blood-based tests, data sets and advanced analytics. It has developed its Guardant360, Guardant360 CDx and GuardantOMNI liquid biopsy-based tests for advanced stage cancer. It also developed its Guardant Reveal liquid biopsy-based test for residual and recurring cancer to address the need in Stage II-III colorectal cancer. Its Guardant360 test is a molecular diagnostic test measuring 74 cancer-related genes. Its Guardant360 CDx test is a liquid biopsy test measuring 55 cancer related genes. Its GuardantOMNI test has a broader 500-gene panel, all of which analyze circulating tumor Deoxyribonucleic Acid (DNA) in blood. The Company's tests are used by biopharmaceutical companies for a range of applications, including identifying target patient populations to accelerate translational science research and clinical trial enrollment, and companion diagnostic development.

==Grafic actiuni companie==
<iframe key="tradeville" path="graficSimbol/US.GH" />

==Ultimele stiri despre GUARDANT HEALTH INC (US.GH)==
<dynamicpagelist>
category=US.GH
count=10
order=descending
addfirstcategorydate=false
</dynamicpagelist>

[[Categorie:US.GH]][[Categorie:Stiri despre companii]]